Danielle is a health law attorney focused on transactions and regulatory compliance. She helps clients navigate the complexities of health care industry mergers and acquisitions, divestitures, joint ventures and co-management agreements, venture capital and private equity investments, public offerings, and recapitalizations. Danielle advises clients on sophisticated deal transactions in nuanced health care sectors, assisting with due diligence, pre- and post-transaction compliance, licensing, regulatory filings, risk mitigation, and operational transition issues. She also regularly counsels clients on technical federal and state health law matters, including fraud and abuse, privacy and data breach incidents, Medicare and Medicaid reimbursement-related issues and audits, corporate practice of medicine and fee-splitting prohibitions, and general corporate compliance. Danielle is considered go-to counsel for compliance, training, and advice on HIPAA.
Before joining Cozen O’Connor, Danielle was associate counsel at Penn Medicine Lancaster General Health (LGH) where she negotiated hospital contracts and counseled hospital leadership on HIPAA/HITECH, Stark and Anti-Kickback laws, governance, policy management, medical credentialing, governmental survey preparation and accreditation, regulatory filings, and information security. She negotiated clinical trial sponsorship agreements on behalf of the affiliated research institute and served as a member of the LGH Institutional Review Board. Prior to serving at LGH, Danielle worked at the Hospital of the University of Pennsylvania-Penn Medicine on regulatory and statutory compliance.
Danielle earned her bachelor’s degree in political science from the University of Michigan and her law degree from Temple University Beasley School of Law, where she served as executive editor of the Temple Journal of Science, Technology, and Environmental Law. Danielle also holds a master’s degree in health policy from Thomas Jefferson University College of Population Health.
News
January 09, 2024
PHILADELPHIA, January 9, 2024 — Cozen O’Connor advised Albaron Partners, a middle-market private equity firm focused on founder-led health care companies, in its sale of Albaron Podiatry Holdings LLC d/b/a Beyond Podiatry, a leader in the management of podiatric medicine in the Midwest, to CUC Inc. The deal represents the first private equity exit in U.S. podiatry history.
March 25, 2021
Cozen O'Connor promoted 15 attorneys to member: Donnie Apodaca, Brian Burack, Jason Cabrera, Kristina Cherevas, Jonathan Gale, Matthew Glavin, Yehudah Gordon, Max Kaplan, Jason Kreps, Anna Will Kentz, Daniel Levine, Peter Lim, Matthew Policastro Laura Reinhart, and Danielle Sapega.
May 06, 2020
Greg Fliszar and Danielle Sapega were quoted in The Legal Intelligencer about their pro bono work with the Physician Support Line during the COVID-19 pandemic.
Publications
September 27, 2022
The Office of Civil Rights of the Department of Health and Human Services (“OCR”) announced the resolution of three more right of access cases, bringing the total to a whopping 41 since the start of its drive to increase compliance with this Health Insurance Portability and Accountability Act...
July 01, 2022
Patient privacy concerns are at an all-time high following the Supreme Court’s ruling in Dobbs v. Jackson Women’s Health Organization. Following their statements affirming that abortion constitutes basic and essential health to which every woman should be entitled issued by both Xavier Becerra,...
December 01, 2021
Christopher Raphaely and Danielle Sapega co-authored an article about the Centers for Medicare & Medicaid Services (CMS) hospital price transparency rule, which has been in effect since January 1, 2021.
July 02, 2021
The United States Departments of Health and Human Services, Treasury and Labor released interim final rules (“Rules”) regarding the “No Surprises Act” (“Act”) yesterday. The Rules are effective beginning on January 1, 2022. They cover the requirements for the billing and payment of emergency and...
December 29, 2020
On December 28, 2020, the District Court for the Northern
District of California granted a motion for a preliminary injunction enjoining
the Centers for Medicare and Medicaid Services from implementing the Most
Favored Nation Rule (the “Rule”, summarized in our December
23 post) until the notice...
December 23, 2020
On December 23, 2020, The District Court for the District of
Maryland granted a temporary restraining order temporarily ceasing the
implementation of the Centers for Medicare and Medicaid Services’ (“CMS”) Most
Favored Nations Rule (the “Rule”) for fourteen (14) days. The Rule,
published on...
November 23, 2020
On Friday, November 20, 2020, the Centers for Medicare and
Medicaid Services (“CMS”) released final regulations to remove certain barriers
to the implementation of physician compensation arrangements under value-based
payment arrangements posed by the “Stark” Physician Self-Referral law. The...
November 06, 2020
On October 29, 2020, Governor Wolf signed House Bill 81 into law, creating new minimum education and certification requirements for central service technicians and surgical technicians working in the Commonwealth, and regulating the practice of surgical technology. The Act will take effect on...
June 24, 2020
As we indicated in last week’s blog post , the D.C. Circuit Court’s refusal to uphold HHS’ pharmaceutical price disclosure rule (“RX Rule”) was not a predictor of how the trial court might rule in the closely watched challenge to HHS’ hospital price transparency rule (“Hospital Rule”). In a June...
June 19, 2020
On June 16, the D.C. Circuit Court struck down the Centers for Medicare and Medicaid Services’ (“CMS”) rule issued in May 2019 requiring pharmaceutical companies to disclose the wholesale acquisition cost of drugs over $35 in their direct-to-consumer television advertisements (“RX Rule”). Similar...
May 15, 2020
Danielle Sapega discusses the Pennsylvania attorney general's investigation into nursing homes, the Department of Health's guidance for nursing homes, and the governor's executive order granting immunity to health care workers.
April 28, 2020
On Friday, April 24th, President Trump signed the Paycheck Protection Program and Health Care Enhancement Act (“Act”) into law that will send an additional $75 billion to the Public Health Emergency and Social Services Fund (“Fund”) used to reimburse eligible health care providers for health care...
April 20, 2020
Danielle E. Sapega and Gregory M. Fliszar discuss CMS's new guidance for nursing homes when it comes to reporting confirmed or suspected cases of COVID-19.
April 14, 2020
Danielle Sapega and Gregory M. Fliszar discuss OCR's announcement relaxing HIPAA rules in connection with the good faith participation in the operation of a COVID-19 Community-Based Testing Site(s)
April 03, 2020
The CARES Act (“Act”) appropriates $100 billion to create a
Public Health Social Service Emergency Fund (“Fund”) to prevent, prepare for,
and respond to coronavirus domestically and internationally for necessary
expenses to reimburse, through grants or other mechanisms, eligible health...
March 28, 2020
Members of Cozen O'Connor's Coronavirus Task Force provide analysis of the CARES Act and how it will impact small businesses, distressed industries, employers and employees, taxes, and the health care, real estates, and energy industries.
March 26, 2020
Danielle E. Sapega and Gregory M. Fliszar discuss the latest guidance from OCR on when it is permissible to disclose the minimum necessary information of individuals infected with COVID-19.
March 13, 2020
Gregory M. Fliszar and Danielle Sapega discuss the HIPAA Privacy and Novel Coronavirus bulletin and what providers and covered entities need to know during a public health emergency.
December 19, 2019
In a 2-1 decision published on December 18, 2019, a 5th Circuit panel upheld the Texas District Court’s decision ruling that the ACA individual mandate tax which, since January 2019, has had no monetary consequence, is unconstitutional. Citing the Supreme Court’s 2012 NFIB v. Sebelius opinion, the...
December 03, 2019
As another mark of progress in the fight against opioid
addiction, Governor Wolf signed Senate Bill 572 (the “Act”) into law on
November 27, 2019, requiring prescribing providers (referred to as
“Prescribers”) to take several additional steps before issuing a prescription
for an opioid in...
November 19, 2019
CMS
finalized the Outpatient Prospective Payment System hospital price transparency
rules on November 15, 2019. As of January 1, 2021, hospitals will have to
publicly post (and update annually) two sets of data: first, a comprehensive
list of standard charges for items services offered by the...
June 24, 2019
CMS recently issued long-awaited draft guidance on hospital co-location with other hospitals or healthcare facilities, providing some potential insight on the otherwise ambiguous prohibition on “shared space.” This prohibition loosely stems from the requirement that a Medicare participating...
June 07, 2019
In 2018,
Governor Tom Wolf signed a multitude of bills into law that significantly
impact Pennsylvania health care providers. Compliance deadlines for these new
laws vary. Implementing any new policies or procedures often takes longer than
anticipated, so we strongly recommend taking steps to...
Events & Seminars
Past Events
December 05, 2023
- Philadelphia, PA
December 08, 2021
- Webinar
December 07, 2020
- Webinar
October 08, 2020
- Webinar
February 20, 2020
- Webinar
December 04, 2019
- Philadelphia, PA